共 50 条
Vitamin D Deficiency among HIV Type 1-Infected Individuals in the Netherlands: Effects of Antiretroviral Therapy
被引:129
|作者:
Van Den Bout-Van Den Beukel, Carolien J. P.
Fievez, Lydia
Michels, Meta
Sweep, Fred C. G. J.
Hermus, Ad R. M. M.
Bosch, Marjolein E. W.
Burger, David M.
Bravenboer, Bert
[2
]
Koopmans, Peter P.
Van Der Ven, Andre J. A. M.
[1
]
机构:
[1] Radboud Univ Nijmegen, Med Ctr, Dept Gen Internal Med, NUCI Int Hlth, NL-6500 HB Nijmegen, Netherlands
[2] Catharina Hosp, Dept Gen Internal Med, Eindhoven, Netherlands
关键词:
D O I:
10.1089/aid.2008.0058
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
Vitamin D regulates bone metabolism but has also immunoregulatory properties. In HIV-infected patients bone disorders are increasingly observed. Furthermore, low 1,25(OH)(2)D-3 levels have been associated with low CD4+ counts, immunological hyperactivity, and AIDS progression rates. Few studies have examined the vitamin D status in HIV-infected patients. This study will specifically focus on the effects of antiretroviral agents on vitamin D status. Furthermore, the effect of vitamin D status on CD4 cell recovery after initiation of HAART will be evaluated. Among 252 included patients the prevalence of vitamin D deficiency (<35 nmol/liter from April to September and <25 nmol/liter from October to March) was 29%. Female sex, younger age, dark skin, and NNRTI treatment were significant risk factors in univariate analysis, although in multivariate analyses skin pigmentation remained the only independent risk factor. Median 25(OH)D-3 levels were significantly lower in white NNRTI-treated patients [54.5(27.9-73.8) nmol/liter] compared to white PI-treated patients [77.3 (46.6-100.0) nmol/liter, p = 0.007], while among nonwhites no difference was observed. Both PI-and NNRTI-treated patients had significantly higher blood PTH levels than patients without treatment. Moreover, NNRTI treatment puts patients at risk of elevated PTH levels (>6.5 pmol/liter). Linear regression analysis showed that vitamin D status did not affect CD4 cell recovery after initiation of HAART. In conclusion, 29% of the HIV-1-infected patients had vitamin D deficiency, with skin color as an independent risk factor. NNRTI treatment may add more risk for vitamin D deficiency. Both PI-and NNRTI-treated patients showed higher PTH levels and might therefore be at risk of bone problems. Evaluation of 25( OH) D3 and PTH levels, especially in NNRTI-treated and dark skinned HIV-1-infected patients, is necessary to detect and treat vitamin D deficiency early.
引用
收藏
页码:1375 / 1382
页数:8
相关论文